The store will not work correctly when cookies are disabled.
N-tert-butyl-5,7-dimethyl-2-oxo-3-(2-oxopyrrolidin-1-yl)indoline-3-carboxamide
ID: ALA4874143
PubChem CID: 164627165
Max Phase: Preclinical
Molecular Formula: C19H25N3O3
Molecular Weight: 343.43
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1cc(C)c2c(c1)C(C(=O)NC(C)(C)C)(N1CCCC1=O)C(=O)N2
Standard InChI: InChI=1S/C19H25N3O3/c1-11-9-12(2)15-13(10-11)19(16(24)20-15,17(25)21-18(3,4)5)22-8-6-7-14(22)23/h9-10H,6-8H2,1-5H3,(H,20,24)(H,21,25)
Standard InChI Key: WRZCDFRSNIHXIJ-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 27 0 0 0 0 0 0 0 0999 V2000
12.3363 -11.2715 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.5426 -12.1506 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4446 -12.3982 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.4435 -13.1847 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1226 -13.5730 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1208 -12.0099 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8005 -12.3946 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.8008 -13.1847 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.5466 -13.4265 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.0097 -12.7892 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.7939 -12.7890 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.2484 -11.7378 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9224 -10.5846 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4544 -9.8122 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5753 -10.0186 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5000 -10.9184 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.7274 -11.3858 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.2439 -10.9207 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.0367 -11.9483 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.6140 -11.3700 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.4036 -11.5808 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4019 -10.5808 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1882 -10.7844 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.7377 -11.9882 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1228 -14.3902 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 4 2 0
4 5 1 0
5 8 2 0
7 6 2 0
6 3 1 0
7 8 1 0
8 9 1 0
9 10 1 0
10 2 1 0
2 7 1 0
10 11 2 0
2 12 1 0
1 13 1 0
13 14 1 0
14 15 1 0
15 16 1 0
16 1 1 0
16 17 2 0
12 18 2 0
12 19 1 0
19 20 1 0
20 21 1 0
20 22 1 0
20 23 1 0
3 24 1 0
5 25 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 343.43 | Molecular Weight (Monoisotopic): 343.1896 | AlogP: 1.99 | #Rotatable Bonds: 2 |
Polar Surface Area: 78.51 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 12.47 | CX Basic pKa: ┄ | CX LogP: 1.88 | CX LogD: 1.88 |
Aromatic Rings: 1 | Heavy Atoms: 25 | QED Weighted: 0.81 | Np Likeness Score: -0.40 |
References
1. Brandão P, López Ó, Leitzbach L, Stark H, Fernández-Bolaños JG, Burke AJ, Pineiro M.. (2021) Ugi Reaction Synthesis of Oxindole-Lactam Hybrids as Selective Butyrylcholinesterase Inhibitors., 12 (11.0): [PMID:34795859] [10.1021/acsmedchemlett.1c00344] |